Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoxic cell sensitisers in radiotherapy.

G E Adams, S Dische, J F Fowler

    Lancet (London, England)
    |January 24, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of Deciduous Molars.

    International dental journal (Philadelphia, Pa.)·2023
    Same author

    Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.

    Radiation research·2012
    Same author

    Summary of meeting on "Radiobiological modelling in treatment planning" at the BIR on 12 December 2006.

    The British journal of radiology·2008
    Same author

    Optimum overall times II: Extended modelling for head and neck radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2007
    Same author

    Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2007
    Same author

    Biologically effective doses in radiotherapy of cervical carcinoma*.

    Neoplasma·2004
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Hypoxic tumor cells resist radiation therapy. Chemical radiosensitizers, mimicking oxygen, selectively target these resistant cells, showing promise for improved cancer treatment outcomes.

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Medical Physics

    Background:

    • Solid tumors often contain hypoxic (low oxygen) cells.
    • Hypoxic cells exhibit significant resistance to conventional radiation therapy.
    • This resistance poses a major challenge in achieving effective cancer treatment.

    Purpose of the Study:

    • To review methods for overcoming radiation resistance in hypoxic tumor cells.
    • To summarize the role and potential of chemical radiosensitizers.
    • To present findings from in vitro, in vivo, and preliminary clinical studies.

    Main Methods:

    • Review of existing clinical approaches like hyperbaric oxygen and heavy particle therapy.
    • Focus on chemical radiosensitizers that mimic oxygen's sensitizing effect.

    Related Experiment Videos

  • Inclusion of in vitro, in vivo experimental data, and early clinical trial results.

    • Main Results:

    • Chemical radiosensitizers are active specifically against hypoxic cells.
    • These agents do not enhance radiation effects in well-oxygenated normal tissues.
    • Radiosensitizers exhibit favorable pharmacokinetics, reaching hypoxic cells effectively.

    Conclusions:

    • Chemical radiosensitizers represent a promising strategy to enhance radiation therapy efficacy.
    • Their selective action on hypoxic tumor cells minimizes damage to healthy tissues.
    • Further clinical investigation is warranted based on promising preclinical and preliminary clinical data.